Urticaria-angioedema and nonurticarial angioedema

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 8, Issue 3, 2000, Pages 239-244

  Haydon, Richard ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOCAPROIC ACID; ANDROGEN; ANTIFIBRINOLYTIC AGENT; BETA LACTAM ANTIBIOTIC; BRONCHODILATING AGENT; CETIRIZINE; COMPLEMENT; CORTICOSTEROID; CYCLOSPORIN A; DANAZOL; DEXAMETHASONE; DOXEPIN; FEXOFENADINE; FOOD ALLERGEN; FRESH FROZEN PLASMA; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; LATEX; LEVOTHYROXINE; LORATADINE; PROTAMINE; STANOZOLOL; SULFONAMIDE; TRANEXAMIC ACID; TRICYCLIC ANTIDEPRESSANT AGENT;

ALLERGY; ANGIONEUROTIC EDEMA; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG CHOICE; DRUG INDICATION; FOOD ALLERGY; HUMAN; IMMUNOPATHOGENESIS; INSECT STING; LIVER CELL CARCINOMA; LONG TERM CARE; MAST CELL DEGRANULATION; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; URTICARIA;

EID: 0034463660     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200006000-00021     Document Type: Review

References (82)

1. Urticaria and angioedema: A review of 544 patients
2. The incidence and familial occurrence of allergy
3. The atopic factor in urticaria
4. Assessment of urticaria and angio-edema
5. Pediatric angioedema: Ten years' experience
6. Urticaria and angioedema: Diagnostic and treatment considerations
7. Chronic urticaria
8. Angioedema: Frightening and frustrating
9. The pathogenesis of idiopathic urticaria
10. Anamnese en diagnostiek an chroniche urticaria
11. Laboratory test in chronic urticaria
12. Urticaria: Then and now
13. Chronic urticaria and angioedema associated with thyroid autoimmunity: Review and therapeutic implications
14. The pathogenesis of chronic idiopathic urticaria: New evidence suggests an autoimmune basis and implications for treatment
15. Anti-Fc εR1 autoantibodies and basophil histamine releasability in chronic idiopathic urticaria
16. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria
17. Chronic idiopathic urticaria: Comparison of the clinical features of patients with and without anti-FceRI or anti-IgE autoantibodies
18. Association of chronic urticaria and angioedema with thyroid autoimmunity
19. The association of chronic urticaria with thyroid autoimmunity: A study of 90 patients
20. Urticaire chronique et pathologie thyroidienne auto-immune
21. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: A study of 90 patients
22. Resolution of chronic urticaria in patients with thyroid autoimmunity
23. Steroid-resistant chronic urticaria associated with anti-thyroid microsomal antibodies in a nine-year-old boy
24. The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema
25. Chronic idiopathic (?) urticaria: A satisfactory outcome
26. Angioneurotic edema with acquired C1 inhibitor deficiency and autoantibody to C1 inhibitor: Response to plasmapheresis and cytotoxic therapy
27. Oral manifestations of systemic disease
28. Allergy and risk of cancer: A prospective study using NHANESI follow-up data
29. Chronic urticaria and cancer: An epidemiological study of 1155 patients
30. Histamine wheal formation and absorption in man
31. The effects of astemizole and indomethacin on wheal and flare reactions to histamine: 48/80 and house dust mite antigen
32. Circulating immunoglobulin E (IgE) antibodies to L-thyroxine in a euthyroid patient with multinodular goiter and allergic rhinitis
33. Chronic urticaria associated with exogenous thyroid use
34. The physical urticarias: An update and review
35. The autologous serum skin test: A screening test for autoantibodies in chronic idiopathic urticaria
36. Recurrent urticaria: Clinical investigation of 330 patients
37. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic uricaria
38. Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI, a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?
39. Asessment of autoimmunity in patients with chronic urticaria
40. Human leukocyte antigen class II associations in chronic idiopathic urticaria
41. Tranexamic acid: Preoperative prophylactic therapy for patients with hereditary angioneurotic edema
42. Prophylactic use of epsilon-aminocaproic acid for oral surgery in a patient with hereditary angioneurotic edema
43. Plasmapheresis for severe, unremitting, chronic urticaria
44. Response of severe chronic urticaria to intravenous immunoglobulin (IVIG)
45. Hereditary angi-oededema: New clinical observations and autoimmune screening, complement and kallikrein-kinin analyses
46. Predicting airway risk in angioedem: Staging system based on presentation
47. Angioedema due to ace inhibitors
48. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition
49. Increased sensitivity to bradykinin among African-Americans
50. Angiotensin converting enzyme inhibitor-induced angioedema more prevalent in transplant patients
51. Adverse effects of the angiotensin-converting enzyme inhibitors
52. The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures
53. Hereditary and acquired C1-inhibitor deficiency: Biological and clinical characteristics in 235 patients
54. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study
55. Haemostasis contact system and fibrinolysis in hereditary angioedema
56. Complement in the pathophysiology of human disease
57. Pathways of kinin formation and role in allergic diseases
58. Angioedema due to ace inhibitors: Common and inadequately diagnosed
59. Angioedema in the emergency department: The impact of angiotensin-converting enzyme inhibitors
60. Angioedema: Five years experience, with review of the disorder's presentation and treatment
61. Glottic angioedema, ciprofloxacin and ACE inhibitors
62. Angiotensin-converting enzyme inhibitor-induced angioedema: Late onset, irregular course, and potential role of triggers
63. Angioedema induced by the angiotensin II blocker Losartan
64. C1 inhibitor and diagnosis of hereditary angioedema in newborns
65. Re: Case presentations on angioedema
66. Quincke's edema, revisited
67. Hereditary angioedema
68. Replacement therapy in hereditary angioedema: Successful treatment of two patients with fresh frozen plasma
69. C1-INH concentrate in the therapy of hereditary angioedema
70. A herediter angioneuroticus oedema gyogyszers kezelese
71. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate
72. Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema
73. Idiopathic nonhistaminergic angioedema
74. Tranexamic acid therapy in hereditary angioneurotic edema
75. Hepatic function and fibrinolysis in patients with hereditary angioedema undergoing long-term treatment with tranexamic acid
76. Clinical application of inhibitors of fibriolysis
77. Role of the second component angioneurotic edema (HANE) plasma
78. Tonsillectomy in a patient with hereditary angioedema after prophylaxis with C1 inhibitor concentrate
79. Hereditary angioneurotic edema: The use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery
80. The use of C1 inhibitor for short-term preoperative prophylaxis in two patients with hereditary angioedema